Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03866733Completed
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: effectiveness of perioperative analgesia. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03866733.